These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18418907)

  • 1. FDA approves new drug for specific type of advanced breast cancer.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual-action drug approved for use in advanced breast cancer.
    McBride D
    ONS Connect; 2007 Jun; 22(6):19. PubMed ID: 17598617
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA announces fast track approval of new drug for lung cancer.
    Dyer O
    BMJ; 2003 May; 326(7397):1004. PubMed ID: 12742913
    [No Abstract]   [Full Text] [Related]  

  • 4. Femara approved as first-line breast cancer therapy.
    FDA Consum; 2001; 35(3):5. PubMed ID: 11458552
    [No Abstract]   [Full Text] [Related]  

  • 5. Herceptin : new treatment and new questions.
    Tecnologica; 1998 Oct; ():15-6. PubMed ID: 10343050
    [No Abstract]   [Full Text] [Related]  

  • 6. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swimming upstream: an advocate reflects on cancer research and social realities.
    Mayer M
    J Clin Oncol; 2008 Jun; 26(16):2783-6. PubMed ID: 18509190
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA advisors recommend approval of taxol for node-positive breast cancer.
    Oncologist; 1999; 4(5):430-1. PubMed ID: 10551561
    [No Abstract]   [Full Text] [Related]  

  • 9. Better prioritization may speed approval of adjuvant therapies in breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2008 Jun; 100(12):842-4. PubMed ID: 18544735
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves sorafenib for patients with inoperable liver cancer.
    Lang L
    Gastroenterology; 2008 Feb; 134(2):379. PubMed ID: 18242200
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves extra safe chemotherapy drug.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):618-9. PubMed ID: 12503201
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves Gleevec for leukemia treatment.
    FDA Consum; 2001; 35(4):6. PubMed ID: 11692893
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioregulatory niches in breast cancer.
    Sledge GW
    Clin Breast Cancer; 2006 Aug; 7(3):200. PubMed ID: 16942636
    [No Abstract]   [Full Text] [Related]  

  • 14. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
    Medina PJ; Goodin S
    Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA Oncology Committee debates Iressa's status following negative trial results.
    Twombly R
    J Natl Cancer Inst; 2005 Apr; 97(7):473. PubMed ID: 15812066
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
    Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
    Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of studies on new medicines in major medical journals: a case study in breast cancer.
    Vitry AI
    Clin Pharmacol Ther; 2010 Apr; 87(4):398-400. PubMed ID: 20305673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing in on a cure.
    Healy B
    US News World Rep; 2006 Oct; 141(15):67. PubMed ID: 17432437
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves regorafenib (Stivarga) for metastatic colorectal cancer.
    Oncology (Williston Park); 2012 Oct; 26(10):896. PubMed ID: 23175993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.